ConductScience.org, home

Paper7808002

The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.

Brieger J and 5 others. Leukemia, 1994. Cited by 110 papers, by iCite.

Cite this record

ConductScience Library. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Papers, record 7808002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7808002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.
PubMed
Journal
Leukemia
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
110
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2022-04-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brieger JJ
2Weidmann EE
3Fenchel KK
4Mitrou PSP S
5Hoelzer DD
6Bergmann LL

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genes, Wilms TumorMajor topic
Leukemia, Myeloid, AcuteMajor topic
Adult
Aged
Base Sequence
Blotting, Southern
Gene Expression
Genetic Markers
Humans
Middle Aged
Molecular Sequence Data
Polymerase Chain Reaction
Predictive Value of Tests
RNA, Messenger
Remission Induction
Sensitivity and Specificity
Transcription, Genetic

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.

PMIDTitleJournalYearIn PapersSource
42927137A Case of Idiopathic Hypereosinophilic Syndrome With High WT1 (Wilms' Tumor Gene) mRNA.Cureus2026https://conductscience.org/library/papers/42927137PubMed
40507300RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid Leukemia.Cancers (Basel)2025https://conductscience.org/library/papers/40507300PubMed
39997326Precision Medicine in Myeloid Neoplasia: Challenges and Opportunities.J Pers Med2025https://conductscience.org/library/papers/39997326PubMed
36960966Therapeutic Effects of WT1 Silencing via Respiratory Administration of Neutral DOPC Liposomal-siRNA in a Lung Metastasis Melanoma Murine Model.Noncoding RNA2023https://conductscience.org/library/papers/36960966PubMed
35743376The Role of Wilms' Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia.J Clin Med2022https://conductscience.org/library/papers/35743376PubMed
33917307WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.Biomedicines2021https://conductscience.org/library/papers/33917307PubMed
33224559Molecular update on biology of Wilms Tumor 1 gene and its applications in acute myeloid leukemia.Am J Blood Res2020https://conductscience.org/library/papers/33224559PubMed
30992690The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.Cancer Cell Int2019https://conductscience.org/library/papers/30992690PubMed
26622998Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances.Ther Adv Hematol2015https://conductscience.org/library/papers/26622998PubMed
24293280Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone.Int J Hematol2014https://conductscience.org/library/papers/24293280PubMed
21643023Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT.Bone Marrow Transplant2012https://conductscience.org/library/papers/21643023PubMed
20048335K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.Clin Cancer Res2010https://conductscience.org/library/papers/20048335PubMed
17690705Effective treatment of leukemic cell lines with wt1 siRNA.Leukemia2007https://conductscience.org/library/papers/17690705PubMed
17361230A tumor suppressor and oncogene: the WT1 story.Leukemia2007https://conductscience.org/library/papers/17361230PubMed
15365188Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15365188PubMed
15175906WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.Cancer Immunol Immunother2004https://conductscience.org/library/papers/15175906PubMed
15168592Clinical significance of minimal residual disease in childhood acute myeloid leukemia.Int J Hematol2004https://conductscience.org/library/papers/15168592PubMed
12894852Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.Int J Hematol2003https://conductscience.org/library/papers/12894852PubMed
12841384The lck promoter-driven expression of the Wilms tumor gene WT1 blocks intrathymic differentiation of T-lineage cells.Int J Hematol2003https://conductscience.org/library/papers/12841384PubMed
12215010Cancer immunotherapy targeting WT1 protein.Int J Hematol2002https://conductscience.org/library/papers/12215010PubMed

See all 30 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene
WT17490PubTator's text mininghttps://conductscience.org/library/genes/7490NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7808002

GET https://conductscience.org/api/papers/v1/7808002/cited_by?page=2